IMV Inc. (IMVIF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 28.88 Million USD | 47.16% |
| 2021 | 19.62 Million USD | 146.33% |
| 2020 | 7.96 Million CAD | 5.77% |
| 2019 | 7.53 Million CAD | 7.76% |
| 2018 | 6.99 Million USD | 33.99% |
| 2017 | 5.21 Million USD | 13.8% |
| 2016 | 4.58 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 Q3 | 28.6 Million USD | -3.93% |
| 2022 FY | 28.88 Million USD | 47.16% |
| 2022 Q2 | 29.77 Million USD | 49.48% |
| 2022 Q4 | 28.88 Million USD | 0.97% |
| 2022 Q1 | 19.92 Million USD | 1.5% |
| 2021 Q3 | 8.22 Million USD | 0.0% |
| 2021 Q4 | 19.62 Million USD | 138.66% |
| 2021 FY | 19.62 Million USD | 146.33% |
| 2020 FY | 7.96 Million CAD | 5.77% |
| 2019 FY | 7.53 Million CAD | 7.76% |
| 2018 FY | 6.99 Million USD | 33.99% |
| 2017 FY | 5.21 Million USD | 13.8% |
| 2016 FY | 4.58 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 29.899% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -600.733% |
| SQZ Biotechnologies Company | 27.47 Million USD | -5.143% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 33.406% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 2.967% |
| Mesoblast Limited | 118.7 Million USD | 75.667% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -2945.954% |
| Genus plc | 233.1 Million USD | 87.609% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -885.668% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -2049.765% |
| Marizyme, Inc. | 18.71 Million USD | -54.315% |
| ContraFect Corporation | 2.88 Million USD | -902.565% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -3751.186% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -21218.575% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -1897.063% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -1141.808% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -410.465% |
| MultiCell Technologies, Inc. | 202.58 USD | -14257920.535% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 49.758% |
| EV Biologics, Inc. | 1.49 Million USD | -1832.355% |
| Q BioMed Inc. | 4.1 Million USD | -602.774% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 12.74% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -4484.185% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -2251.418% |
| Biomind Labs Inc. | 735.54 Thousand USD | -3826.886% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 83.162% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -122.235% |
| Skye Bioscience, Inc. | 4.61 Million USD | -525.834% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -3152.457% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -20310.052% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -391.968% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -112205.681% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -1178.965% |
| GB Sciences, Inc. | 1.75 Million USD | -1541.777% |
| Alpha Cognition Inc. | 1.22 Million USD | -2266.811% |
| HST Global, Inc. | 98.31 Thousand USD | -29277.738% |
| CSL Limited | 12.18 Billion USD | 99.763% |
| Halberd Corporation | 150 Thousand USD | -19155.932% |
| Enzolytics Inc. | 996.33 Thousand USD | -2799.006% |
| Resverlogix Corp. | 6.49 Million USD | -344.984% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -5948.984% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -11200.783% |
| argenx SE | 20 Million USD | -44.419% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 36.603% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -966.337% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -282383.11% |
| Genscript Biotech Corporation | 417.73 Million USD | 93.086% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -14297.604% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -1104.638% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -12497.048% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 57.299% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -854.464% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -7929.773% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -42.089% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -19330.286% |
| BioStem Technologies, Inc. | 4.71 Million USD | -513.062% |
| ONE Bio Corp. | 19.71 Million USD | -46.507% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -11445.154% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -11513.018% |
| Agentix Corp. | 50 Thousand USD | -57667.796% |
| LadRx Corporation | 33.6 Thousand USD | -85848.634% |
| Cell Source, Inc. | 9.25 Million USD | -212.118% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -3719.591% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -3719.591% |
| NovAccess Global Inc. | 2.19 Million USD | -1212.976% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -308.379% |
| Itoco Inc. | 228.37 Thousand USD | -12547.464% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -13590.673% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -479.649% |
| Kadimastem Ltd | 891.22 Thousand USD | -3140.917% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -7087.749% |
| CytoDyn Inc. | 30.07 Million USD | 3.964% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -5864.248% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -8109.221% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -269.361% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -23478.692% |
| Rebus Holdings, Inc. | 310 Thousand USD | -9217.386% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -509.972% |
| International Stem Cell Corporation | 4.17 Million USD | -591.333% |
| Bioxytran, Inc. | 1.92 Million USD | -1400.462% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -46178.657% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -1224.403% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -247.329% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -236.446% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -1756.913% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -10677.574% |
| Neutra Corp. | 54.15 Thousand USD | -53234.622% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -1478.355% |
| PureTech Health plc | 25.51 Million USD | -13.217% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -2259.36% |
| IXICO plc | 472.02 Thousand USD | -6019.172% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -86.336% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 53.61% |
| CSL Limited | 12.18 Billion USD | 99.763% |
| Cellectis S.A. | 92.77 Million USD | 68.867% |